Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin irritation / corrosion

Currently viewing:

Administrative data

Endpoint:
skin irritation: in vitro / ex vivo
Type of information:
experimental study
Adequacy of study:
key study
Study period:
22 September 2020 - 28 September 2020
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2020
Report date:
2020

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
EU Method B.46 (In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test)
Version / remarks:
20 July 2012
Deviations:
no
Qualifier:
according to guideline
Guideline:
OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
Version / remarks:
18 June 2019
Deviations:
no
GLP compliance:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
N1,N3‐bis(3‐methylphenyl)‐5‐[(3‐methylphenyl)sulfamoyl]benzene‐1,3‐dicarboxamide
Molecular formula:
C29H27N3O4S
IUPAC Name:
N1,N3‐bis(3‐methylphenyl)‐5‐[(3‐methylphenyl)sulfamoyl]benzene‐1,3‐dicarboxamide
Test material form:
solid: particulate/powder
Details on test material:
- Appearance: Off-white powder
- Storage condition: At room temperature protected from light

In vitro test system

Test system:
human skin model
Source species:
human
Cell type:
other: epidermal keratinocytes
Cell source:
other: SkinEthic Laboratories, Lyon, France.
Source strain:
other: not applicable.
Vehicle:
unchanged (no vehicle)
Details on test system:
RECONSTRUCTED HUMAN EPIDERMIS (RHE) TISSUE
- Model used: EPISKIN Small ModelTM (EPISKIN-SMTM, 0.38 cm^2)
- Tissue batch number(s): 20 EKIN 039

TEMPERATURE USED FOR TEST SYSTEM
- Temperature used during treatment / exposure: 37°C
- Temperature of post-treatment incubation (if applicable): 37°C

REMOVAL OF TEST MATERIAL AND CONTROLS
- Washing: phosphate buffered saline
- Time after start of exposure: 15 minutes

TEST FOR DIRECT MTT REDUCTION AND COLOUR INTERFERENCE
The test item has been tested previously for possible direct MTT reduction and color interference in the Skin corrosion test using Epiderm as a skin model (Test Facility Study No. 20256931).

MTT DYE USED TO MEASURE TISSUE VIABILITY AFTER TREATMENT / EXPOSURE
- MTT concentration: 0.3 mg/mL
- Incubation time: 3 hours
- Microplate reader: TECAN Infinite® M200 Pro Plate Reader
- Wavelength: 570 nm

NUMBER OF REPLICATE TISSUES: 3

NUMBER OF INDEPENDENT TEST SEQUENCES / EXPERIMENTS TO DERIVE FINAL PREDICTION:
1 exposure time.

EVALUATION
The corrected OD (ODc) for each sample or control will be calculated by subtracting the value of the blank mean (ODbl) from each reading (ODraw).
ODc = ODraw – ODbl
The OD value representing 100% cell viability is the average OD of the negative controls (ODlt_u+MTT).
The %Viability for each sample and positive control is calculated as follows:
%Viability = (ODc/mean ODlt_u+MTT) * 100

PREDICTION MODEL / DECISION CRITERIA: see Table 1.

ACCEPTABILITY CRITERIA:
The in vitro skin irritation test is considered acceptable if it meets the following criteria:
a) The absolute mean OD570 of the three tissues of the negative control should reasonably be within the laboratory historical control data range and the acceptance limits of OECD439 (lower acceptance limit ≥0.6 and upper acceptance limit ≤ 1.5) and the Standard Deviation value (SD) of the % viability should be ≤18.
b) The mean relative tissue viability of the positive control should be ≤40% relative to the negative control and the Standard Deviation value (SD) of the % viability should be ≤18.
c) The SD calculated from individual % tissue viabilities of the three identically treated replicates should be ≤18.
d) The %NSCliving should be ≤ 30% relative to the negative control OD.
Control samples:
yes, concurrent negative control
yes, concurrent positive control
Amount/concentration applied:
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 15.1 to 24.8 mg (moistened with 5 µL Milli-Q water)

NEGATIVE CONTROL
- Amount(s) applied (volume or weight): 25 μL Phosphate buffered saline (PBS)

POSITIVE CONTROL
- Amount(s) applied (volume or weight): 25 μL 5% (aq) Sodium dodecyl sulfate (SDS)
Duration of treatment / exposure:
15 minutes
Duration of post-treatment incubation (if applicable):
42 hours
Number of replicates:
3

Results and discussion

In vitro

Results
Irritation / corrosion parameter:
% tissue viability
Run / experiment:
15 minutes exposure
Value:
96
Vehicle controls validity:
not applicable
Negative controls validity:
valid
Remarks:
100
Positive controls validity:
valid
Remarks:
14
Remarks on result:
no indication of irritation
Other effects / acceptance of results:
- OTHER EFFECTS:
- Visible damage on test system: no
- Direct-MTT reduction: no
- Colour interference with MTT: yes
In addition to the normal procedure, three tissues were treated with test item. Instead of MTT solution these tissues were incubated with assay medium. The non-specific color by the test item was 4.66% of the negative control tissues. The OD of the tissues incubated with assay medium was subtracted from the ODs of the test item treated tissues incubated with MTT medium.

ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: The negative control tissues was within the laboratory historical control data range.
- Acceptance criteria met for positive control: The positive control had a mean cell viability after 15 ± 0.5 minutes exposure of 14%.
- Acceptance criteria met for variability between replicate measurements: The standard deviation value of the percentage viability of three tissues treated identically was ≤ 14%, indicating that the test system functioned properly.

Any other information on results incl. tables

Table 1           
Mean Absorption in the In Vitro Skin Irritation Test with Pergafast 425










































 



A


(OD570)



B


(OD570)



C


(OD570)



Mean


(OD570)



 



SD



Negative control



0.976



0.906



1.172



1.018



±



0.138



Test item



1.080



0.890



0.972



0.980



±



0.095



Positive control



0.219



0.113



0.100



0.144



±



0.065



OD = optical density


SD = Standard deviation


(1) The test item values are corrected for the non-specific color interference.


Triplicate exposures are indicated by A, B and C.


In this table the values are corrected for background absorption (0.0431). Isopropanol was used to measure the background absorption.


Table 2           
Mean Tissue Viability in the In Vitro Skin Irritation Test with Pergafast 425


























 



Mean tissue viability (percentage of control)



Standard deviation (percentage)



Negative control



100



14



Test item



96



9.3



Positive control



14



6.4



 

Applicant's summary and conclusion

Interpretation of results:
other: Not a skin irritant. According to Regulation (EC) No. 1272/2008 and its amendments.
Conclusions:
The in vitro skin irritation test was conducted according to OECD 439 guideline and GLP principles.
Since the mean relative tissue viability for the substance was above 50%, the substance is considered to be not irritant.
Executive summary:

The substance was tested in triplicate in an in vitro skin irritation test according to OECD TG 439 test guideline and GLP principles. Tissues were exposed to the substance, a negative control (PBS) and a positive control (5% SDS) for 15 minutes. The substance was tested for direct MTT reduction and colour interference.


The solutions did not turn blue / purple, nor a blue / purple precipitate was observed. The OD for the test item solution was >0.08, it was concluded that the test item did interfere with the MTT endpoint. In addition to the normal procedure, three tissues were treated with test item. Instead of MTT solution these tissues were incubated with assay medium. The non-specific color by the test item was 4.66% of the negative control tissues. The OD of the tissues incubated with assay medium was subtracted from the ODs of the test item treated tissues incubated with MTT medium.


Acceptability criteria for the negative control, positive control and variability between measurements were met.
The cell viability of the tissues exposed to the substance was 96% for 15 minutes exposure. Since the mean relative tissue viability for the substance was above 50%, the substance is considered to be not irritant.